Fans of wearable devices in more countries might start considering using the Samsung Galaxy Watch 3 or Watch Active 2 as their vital health monitoring features will be available soon. The tech company acquired the necessary permissions for its Health Monitor app to function in a total of 31 countries.
Samsung’s advanced health monitoring services cleared for use in more countries
The Samsung Galaxy Watch 3 and Watch Active 2 are equipped with sensors that allow them to monitor a user’s blood pressure and function with electrocardiogram (ECG) tracking. However, reading this data would require the Samsung Health Monitor app.
Like other health and medical products, the Samsung Health Monitor app needed to be approved in different countries following different regulations. It explains why tech features of this nature typically launch in limited territories. However, this changes for Samsung after the company acquired CE-marking last December for the software product allowing it to launch in European countries.
Samsung Galaxy Watch 3 and Watch Active 2 users Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom will soon be able to use the said app for BP and ECG tracking. The app is also launching in Chile, Indonesia, and the UAE making it available in 31 countries after only being accessible in South Korea.
Once the Samsung Health Monitor app goes live in the said countries, Samsung Galaxy Watch 3 and Watch Active 2 have to be updated to their latest versions. Doing so will automatically install the app on the wearable devices. Updates can be initiated through the Galaxy Wearable app via a paired Galaxy smartphone.
Samsung Galaxy Watch 4 rumored to launch with blood sugar level sensor
Having a blood pressure and ECG monitor on people’s wrists through devices like Samsung Galaxy Watch 3 and Watch Active 2 is already a notable technological development. But the company is reportedly looking to add another essential medical tracker in its upcoming Galaxy Watch 4.
ET News reported that Samsung is planning to launch the Galaxy Watch 4 with blood sugar level tracking this year. It is expected to use optic sensors that would allow measure blood glucose levels without blood sampling.


Coupang Apologizes After Massive Data Breach Affecting 33.7 Million Users
Apple Appoints Amar Subramanya as New Vice President of AI Amid Push to Accelerate Innovation
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation
Nexperia Urges China Division to Resume Chip Production as Supply Risks Mount
Morgan Stanley Boosts Nvidia and Broadcom Targets as AI Demand Surges
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup
Intel Boosts Malaysia Operations with Additional RM860 Million Investment
Apple Leads Singles’ Day Smartphone Sales as iPhone 17 Demand Surges
Quantum Systems Projects Revenue Surge as It Eyes IPO or Private Sale
Samsung Launches Galaxy Z TriFold to Elevate Its Position in the Foldable Smartphone Market
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
Apple Alerts EU Regulators That Apple Ads and Maps Meet DMA Gatekeeper Thresholds
Banks Consider $38 Billion Funding Boost for Oracle, Vantage, and OpenAI Expansion 



